Objective Emulsar is an innovative SME founded in 2004. Emulsar invented a breakthrough emulsion technology that allows the designing and manufacturing of disruptive innovations to revolutionize health and nutrition. Since 2012 Emulsar has produced hundreds of tons of Light oil® used to bring a whole new generation of ultra low-fat and healthier dressings with enhanced taste on the market.The combination of aging populations, more sedentary lifestyles and poor nutrition habits has created a huge raise in public health issues such as diabetes, obesity, Alzheimer, denutrition and cancer. Health goes through nutrition.Today, poor taste is one of the main criticisms heard about healthy functional food, and undoubtedly the major reason for poor consumption. Nutrition demands taste.Our objective and main motivation for this project proposal are to accelerate the deployment of our innovative manufacturing technology on a European & world scale by investigating functional food market opportunities. Emulsar’s mission is to improve the health impact of functional food through enhanced taste.The deployment of such a technology will lead to these outcomes: • identify the most valuables functional food products in terms of nutrition impact and business opportunity for Europe & the world• produce lab prototypes• generate market data to forecast turnover and ROI• build a strong business planThese outcomes will also lead to the following impacts:• positively modify patient and consumer perception of functional food• dramatically increase consumption of functional food in Europe and around the world• help solving chronic diseases and face the aging of populationThe objectives of phase 1 are to conduct a global market study and realize prototypes to be used as proof of concept. The success of phase 1 will lead to industrialize and commercialize our application in phase 2 and start developing new promising applications.Emulsar: give the world appetite for health. Fields of science medical and health scienceshealth sciencespublic healthmedical and health sciencesbasic medicineneurologydementiaalzheimermedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsmedical and health sciencesclinical medicineendocrinologydiabetesmedical and health scienceshealth sciencesnutritionobesity Programme(s) H2020-EU.2.1.2. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) NMP-25-2014-1 - Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2014 Funding Scheme SME-1 - SME instrument phase 1 Coordinator EMULSAR Net EU contribution € 50 000,00 Address 26-28 rue Marius Aufan 92300 Levallois-Perret France See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Ile-de-France Ile-de-France Hauts-de-Seine Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00